Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neogen Corporation - Common Stock (NQ:NEOG)

6.140 -0.050 (-0.81%)
Streaming Delayed Price Updated: 1:12 PM EDT, Oct 27, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Neogen Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
3 Russell 2000 Stocks We Find Risky
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the... 
Via StockStory
5 Revealing Analyst Questions From Neogen’s Q3 Earnings Call
Neogen’s third quarter results were met with a strong positive market reaction, despite reporting a year-over-year sales decline. Management attributed the quarter’s performance to ongoing operational... 
Via StockStory
Topics Earnings
2 Unprofitable Stocks for Long-Term Investors and 1 We Question
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to convert spending into sustainable growth. 
Via StockStory
What to Expect from Neogen's Earnings
 
Via Benzinga
Earnings Scheduled For July 29, 2025
 
Via Benzinga
Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know
A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. 
Via StockStory
Topics Economy Government World Trade
NEOG Q3 Deep Dive: Q3 Results, Guidance Reaffirmed, and Operational Turnaround in Focus
Life sciences company Neogen (NASDAQ:NEOG) reported Q3 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 3.6% year on year to $209.2 million. The company’s full-year revenue... 
Via StockStory
Animal Tester Neogen Sticks To Annual Forecast Despite Tariffs
Neogen stock rises after Q1 sales beat expectations, driven by food and animal safety growth, while the company maintains full-year 2026 guidance. 
Via Benzinga
Topics Earnings
Why Neogen (NEOG) Stock Is Trading Up Today
Shares of life sciences company Neogen (NASDAQ:NEOG) jumped 21.4% in the morning session after the company reported third-quarter 2025 financial results that surpassed revenue expectations while its... 
Via StockStory
Neogen (NEOG) Q1 2026 Earnings Call Transcript
Via The Motley Fool
Topics Earnings World Trade
Neogen Corp (NASDAQ:NEOG) Reports Mixed Q1 FY2026 Results, Reaffirms Full-Year Outlook
Neogen's Q1 FY2026 results show a mixed performance, with revenue beating estimates but adjusted EPS slightly missing. The stock rose as investors focused on the revenue beat and cost-saving... 
Via Chartmill
Neogen (NASDAQ:NEOG) Exceeds Q3 Expectations, Stock Soars
Life sciences company Neogen (NASDAQ:NEOG) reported Q3 CY2025 results exceeding the market’s revenue expectations, but sales fell by 3.6% year on year to $209.2 million. The company’s full-year revenue... 
Via StockStory
Earnings Scheduled For October 9, 2025
 
Via Benzinga
Neogen (NEOG) Q3 Earnings Report Preview: What To Look For
Life sciences company Neogen (NASDAQ:NEOG) will be reporting results this Thursday morning. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Top Wall Street Forecasters Revamp Neogen Expectations Ahead Of Q1 Earnings
 
Via Benzinga
3 Stocks Under $10 We Approach with Caution
Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be... 
Via StockStory
Neogen (NEOG): Buy, Sell, or Hold Post Q2 Earnings?
Neogen has gotten torched over the last six months - since April 2025, its stock price has dropped 30.9% to $5.80 per share. This may have investors wondering how to approach the situation. 
Via StockStory
Topics Bankruptcy
Neogen (NEOG) Stock Trades Up, Here Is Why
Shares of life sciences company Neogen (NASDAQ:NEOG) jumped 2.6% in the afternoon session after the company's shares rebounded following a series of recent developments, including an upcoming earnings... 
Via StockStory
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers SciSparc (NASDAQ: SPRC) shares increased by 28.2% to $5.68 during Monday's after-market session. The company's market cap stands at $2.2 million. 
Via Benzinga
1 Safe-and-Steady Stock with Exciting Potential and 2 We Question
Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies. 
Via StockStory
Stocks making big moves yesterday: Neogen, Rocket Lab, Hain Celestial, Chewy, and Oscar Health
Check out the companies making headlines yesterday: 
Via StockStory
Why Neogen (NEOG) Stock Is Down Today
Shares of life sciences company Neogen (NASDAQ:NEOG) fell 7.2% in the morning session after the company announced the planned departure of its Chief Financial Officer and Chief Operating Officer, David... 
Via StockStory
Topics Artificial Intelligence Economy World Trade
Oscar Health, Krispy Kreme, Beyond Meat, and Neogen Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after the major indices continued to pull back, with technology stocks accounting for most of the market's largest decliners. A key reason for this... 
Via StockStory
Topics Artificial Intelligence Economy World Trade
Why Neogen (NEOG) Stock Is Up Today
Shares of life sciences company Neogen (NASDAQ:NEOG) jumped 5.2% in the afternoon session after an investment group led by Clarkston Capital Partners disclosed a significant 6.44% stake in the company.... 
Via StockStory
Topics Bonds Economy Stocks
NEOG Q2 Deep Dive: Market Pressures Persist, Regulatory Tailwinds and CEO Transition Shape Outlook
Life sciences company Neogen (NASDAQ:NEOG) reported Q2 CY2025 results exceeding the market’s revenue expectations, but sales fell by 4.8% year on year to $225.5 million. The company’s full-year revenue... 
Via StockStory
Topics Economy World Trade
Inspire Medical Systems, UFP Technologies, Globus Medical, Neogen, and Dentsply Sirona Shares Skyrocket, What You Need To Know
A number of stocks jumped in the afternoon session after positive inflation data fueled hopes for an interest rate cut by the Federal Reserve. 
Via StockStory
Topics Bonds Economy Stocks
3 Small-Cap Stocks with Warning Signs
Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small... 
Via StockStory
Q2 Earnings Highlights: Neogen (NASDAQ:NEOG) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - diversified industry, including Neogen (NASDAQ:NEOG) and its peers. 
Via StockStory
Topics Economy
Neogen (NEOG) Stock Trades Down, Here Is Why
Shares of life sciences company Neogen (NASDAQ:NEOG) fell 10.2% in the morning session after the company reported disappointing fourth-quarter financial results, which showed a decline in revenue and... 
Via StockStory
Topics Economy
Neogen (NASDAQ:NEOG) Posts Better-Than-Expected Sales In Q2, Guides for Strong Full-Year Sales
Life sciences company Neogen (NASDAQ:NEOG) reported Q2 CY2025 results beating Wall Street’s revenue expectations, but sales fell by 4.8% year on year to $225.5 million. The company’s full-year revenue... 
Via StockStory
Topics Economy
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.